HIND: ReShape Lifesciences Analyst Median Target

Corporate company logo of Vyome Holdings Inc. (HIND)

This daily price chart for Vyome Holdings Inc (HIND) reflects the current value of 8.81. Vyome Holdings Inc is currently assessing the efficacy of new molecules against resistant acne in laboratory settings. The implementation of drugs for fungal infections and skin inflammation into medical protocols ensures a steady stream of income. However, geopolitical fragmentation is hindering the procurement of biomaterials and the execution of global clinical trials.

HIND (Vyome Holdings Inc.) Analyst Consensus Forecast history from 08/16/2025 to 11/15/2026

Analytical breakdowns for Vyome Holdings Inc (HIND)

- share price and consensus valuation forecast:
General company analysis:HIND Vyome Holdings Inc.
Flagship merchandise of Vyome Therapeutics

The consensus forecast represents the weighted average fair value of a share, calculated based on the fundamental analysis of future cash flows by leading experts. By analyzing the history of targets from the analytical community, an investor can assess the growth potential of Vyome Holdings Inc (HIND), whose innovative immunological skin treatments create high added value during the business's active scaling phase.

Competitors of Vyome Holdings Inc

Analyst Consensus Forecast argenx N.V. (ARGX)|Price Target Chart BioNTech SE BNTX|Abivax Corp - Price Target Chart|ADMA - Price Target Chart|Analyst Target Range Protagonist (PTGX)|IMVT (Immunovant, Inc.) - Consensus Target|Kiniksa Pharmaceuticals, Ltd. (KNSA) - Analyst Consensus Forecast|Price Target Chart Grifols|Adaptive Biotechnologies Corp - Forecast Levels Chart|Analyst Consensus Forecast CLDX|AUPH (Aurinia Pharmaceuticals) - Fair Value Consensus|Analyst Consensus Forecast BCRX (biocryst.com)|Analyst Consensus Forecast Vera Therapeutics Inc VERA|DNTH - Price Target Chart|Fair Value Consensus PHVS (Pharvaris Pharma)|AbCellera Corp (ABCL) - Price Target Chart|Consensus Target Tourmaline Bio, Inc.|PGEN (precigen.com) - Analyst Consensus Forecast|Analyst Consensus Forecast Pharming|Consensus Target NKTR (Nektar)|Analyst Median Target Upstream Pharma|Analyst Consensus Forecast ZBIO (zenasbio.com)|Analyst Median Target immunome.com (IMNM)|GOSS - Price Target Chart|KalVista Pharma (KALV) - Consensus Target|Septerna Pharma (SEPN) - Price Target Chart|Consensus Target Pieris Pharmaceuticals|Consensus Target SVRA|Analyst Consensus Forecast rigel.com|Price Target Chart AnaptysBio Corp (ANAB)|Astria Therapeutics, Inc. - Broker Consensus Forecast|Analyst Consensus Forecast ENGN (engene.com)|RAPT Therapeutics Inc. (RAPT) - Average Forecast Price|Aerovate Therapeutics Inc - Analyst Consensus Forecast|ACRS - Analyst Consensus Forecast|KYTX (Kyverna Therapeutics, Inc) - Consensus Target|TLSA - Analyst Median Target|CABA (Cabaletta Bio, Inc) - Analyst Consensus Forecast|Broker Consensus Forecast VTYX (Ventyx Biosciences)|Price Target Chart Theratechnologies Inc. (THTX)|Price Target Chart AVTX (avalotx.com)|Price Target Chart Eledon Pharmaceuticals, Inc ELDN|Analyst Consensus Forecast Agenus, Inc. AGEN|CLYM: Consensus Target|ZURA: Price Target Chart|ATYR: Analyst Consensus Forecast|Average Forecast Price Adagene Inc (ADAG)|IMA (Ikena Oncology) - Analyst Consensus Forecast|Analyst Consensus Forecast Shattuck Labs|Analyst Consensus Forecast EQ|Price Target Chart CNTB (Connect Biopharma Holdings Limited)|Price Target Chart immunic-therapeutics.com IMUX|Analyst Forecast Prices ATRA (Atara Biotherapeutics Inc)|IFRX: Consensus Target|X4 Pharmaceuticals, Inc. (XFOR) - Consensus Target|ACET: Analyst Consensus Forecast|CELU - Analyst Median Target|Price Target Chart INmune Bio|Average Forecast Price Barinthus Biotherapeutics plc BRNS|Analyst Consensus Forecast KZR|SABS - Average Forecast Price|Akari Therapeutics Plc - Consensus Target|enlivex.com (ENLV) - Average Forecast Price|QTTB - Price Target Chart|Analyst Median Target GeoVax Labs, Inc. GOVX|EDSA: Analyst Consensus Forecast|iBio Inc - Fair Value Consensus|CARM (Carisma Therapeutics Inc.) - Analyst Consensus Forecast|XTL Biopharmaceuticals, Ltd. (XTLB) - Analyst Median Target|Analyst Consensus Forecast BOLT|HCWB (HCW Biologics) - Fair Value Consensus|Analyst Consensus Forecast APVO (Aptevo Therapeutics, Inc.)|Fair Value Consensus AIM|ADTX: Consensus Target|Fair Value Consensus GRI (GRI Bio Corp)|XRTX: Analyst Consensus Forecast|REVB - Analyst Median Target|Price Target Chart Indaptus|Scinai Immunotherapeutics Ltd. (SCNI) - Analyst Median Target|Price Target Chart CalciMedica Inc (CALI)|AFMD - Average Forecast Price|Price Target Chart Allakos Inc. ALLK|Fair Value Consensus HOOK|IGM Biosciences - Analyst Consensus Forecast|Fair Value Consensus ITOS (iTeos Therapeutics Inc)|OCEA: Analyst Consensus Forecast|Broker Consensus Forecast TCBP|THRD (Third Harmonic Bio Inc) - Analyst Consensus Forecast